You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
of hormonal status and H<strong>ER</strong>-2 in breast cancer--a study from the IMPACT<br />
trialists. J Clin Oncol 23:2477-92<br />
121. Ellis MJ, Tao Y, Young O, White S, Proia AD, Murray J, Renshaw L,<br />
Faratian D, Thomas J, Dowsett M, Krause A, Evans DB, Miller WR, Dixon<br />
JM 2006 Estrogen-independent proliferation is present in estrogen-receptor<br />
H<strong>ER</strong>2-positive primary breast cancer after neoadjuvant letrozole. J Clin Oncol<br />
24:3019-25<br />
122. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP,<br />
McGuffog L, Easton DF 2002 The pathology of familial breast cancer:<br />
predictive value of immunohistochemical markers estrogen receptor, progesterone<br />
receptor, H<strong>ER</strong>-2, and p53 in patients with mutations in BRCA1 and BRCA2. J<br />
Clin Oncol 20:2310-8<br />
123. Poole AJ, Li Y, Kim Y, Lin SC, Lee WH, Lee EY 2006 Prevention of Brca1-<br />
mediated mammary tumorigenesis in mice by a progesterone antagonist. Science<br />
314:1467-70<br />
124. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ,<br />
Edwards BK, Berry DA 2007 The decrease in breast-cancer incidence in 2003 in<br />
the United States. N Engl J Med 356:1670-4<br />
125. Cordera F, Jordan VC 2006 Steroid receptors and their role in the biology and<br />
control of breast cancer growth. Semin Oncol 33:631-41<br />
126. Aupperlee M, Kariagina A, Osuch J, Haslam SZ 2005 Progestins and breast<br />
cancer. Breast Dis 24:37-57<br />
59
Change language